Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil–Based Chemotherapy

Ada Collura , Anaïs Lagrange , Magali Svrcek , Laetitia Marisa , Olivier Buhard , Agathe Guilloux , Kristell Wanherdrick , Coralie Dorard , Anna Taieb , Arnaud Saget , Marie Loh , Richie Soong , Nikolajs Zeps , Cameron Platell , Andrew Mews , Barry Iacopetta , Aurélie de Thonel (1) , Renaud Seigneuric , Guillaume Marcion , Caroline Chapusot , Come Lepage , Anne–marie Bouvier , Marie–pierre Gaub , Gérard Milano , Janick Selves , Patrick Senet , Patrice Delarue , Hayat Arzouk , Claire Lacoste , Arnaud Coquelle , Leila Bengrine–lefèvre , Christophe Tournigand , Jérémie Lefèvre , Yann Parc , Denis Biard , Jean–françois Fléjou , Carmen Garrido , Alex Duval

1 EDC (UMR_7216) - Centre épigénétique et destin cellulaire

Domains: Life Sciences [q-bio]

Ada Collura, Anaïs Lagrange, Magali Svrcek, Laetitia Marisa, Olivier Buhard, et al.. Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil–Based Chemotherapy. Gastroenterology, 2014, 146 (2), pp.401-411.e1. ⟨10.1053/j.gastro.2013.10.054⟩. ⟨hal-03030339⟩